BRENNER LOUIS MD (President and COO) sold 11.0% of their position (25.21K shares) of ALLENA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $28.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/12/2021ACC: 0001209191-21-032076
Officer· President and COO
Since Jan 2019
-25.21K
Net shares
Net seller
$28.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
83.72K acquired · 108.94K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−25.21K
Price / share
$1.11
Trade value
$27.99K
% of position
11.0%
5/10/2021
228.54K→203.32K
Common Stock
Direct
Shares
+83.72K
Price / share
—
Trade value
—
% of position
57.8%
5/10/2021
144.82K→228.54K
Total
Net shares
+58.51K
Net value
-$27.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/10/2021 | S · Sale | −25.21K | $1.11 | $27.99K | 11.0% | 228.54K | 203.32K |
| Common Stock Direct | 5/10/2021 | M · Option Exercise | +83.72K | — | — | 57.8% | 144.82K | 228.54K |
| Total | +58.51K | -$27.99K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
83.72K shares
Shares
−83.72K
Strike price
Held after
125.58K
Exercisable
—
5/10/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock83.72K shares | 5/10/2021 | M · Option Exercise | −83.72K | — | 125.58K |